These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29452521)

  • 1. Clinical trial quality: From supervision to collaboration and beyond.
    Meeker-O'Connell A; Glessner C
    Clin Trials; 2018 Feb; 15(1_suppl):23-26. PubMed ID: 29452521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient engagement in clinical trials: The Clinical Trials Transformation Initiative's leadership from theory to practical implementation.
    Patrick-Lake B
    Clin Trials; 2018 Feb; 15(1_suppl):19-22. PubMed ID: 29452519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing clinical evidence by proactively building quality into clinical trials.
    Meeker-O'Connell A; Glessner C; Behm M; Mulinde J; Roach N; Sweeney F; Tenaerts P; Landray MJ
    Clin Trials; 2016 Aug; 13(4):439-44. PubMed ID: 27098014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?
    Tenaerts P; Madre L; Landray M
    Clin Trials; 2018 Feb; 15(1_suppl):5-12. PubMed ID: 29452517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ensuring trial conduct is consistent with trial design: assumption is the enemy of quality.
    Kelly J; Hounsome B; Lambert G; Murphy C
    Trials; 2019 Jul; 20(1):416. PubMed ID: 31291974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous quality improvement in contract research organizations--the customer focus.
    Sollecito WA; Kaluzny AD
    Qual Manag Health Care; 1999; 7(3):7-21. PubMed ID: 10537463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium.
    Weinreb RN; Kaufman PL
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1497-505. PubMed ID: 19321793
    [No Abstract]   [Full Text] [Related]  

  • 9. The Clinical Trials Transformation Initiative: Methodology supporting the mission.
    Corneli A; Hallinan Z; Hamre G; Perry B; Goldsack JC; Calvert SB; Forrest A
    Clin Trials; 2018 Feb; 15(1_suppl):13-18. PubMed ID: 29452520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Imaging Endpoints in Clinical Trials.
    Gillam LD; Leipsic J; Weissman NJ
    JACC Cardiovasc Imaging; 2017 Mar; 10(3):296-303. PubMed ID: 28279377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interview with Gary L. Yingling, J.D.
    Yingling GL
    Qual Manag Health Care; 1999; 7(3):45-7. PubMed ID: 10537462
    [No Abstract]   [Full Text] [Related]  

  • 12. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
    Hong H; Mackey WC
    Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials registries.
    Somberg J
    Am J Ther; 2003; 10(5):309-10. PubMed ID: 12975713
    [No Abstract]   [Full Text] [Related]  

  • 14. Independent Phantom Irradiation Is Both Necessary and Cost Effective for Clinical Trial Credentialing.
    Science Council and Therapy Physics Committee of the American Association of Physicists in Medicine
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):501-3. PubMed ID: 26068481
    [No Abstract]   [Full Text] [Related]  

  • 15. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium.
    Csaky KG; Richman EA; Ferris FL
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):479-89. PubMed ID: 18234989
    [No Abstract]   [Full Text] [Related]  

  • 16. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Government viewpoint of clinical trials of cardiovascular drugs.
    Temple R
    Med Clin North Am; 1989 Mar; 73(2):495-509. PubMed ID: 2918768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the design of pivotal clinical trials.
    Prasad VK
    Clin Adv Hematol Oncol; 2019 Mar; 17(3):150-152. PubMed ID: 30969951
    [No Abstract]   [Full Text] [Related]  

  • 20. An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials.
    Faris O; Shuren J
    N Engl J Med; 2017 Apr; 376(14):1350-1357. PubMed ID: 28379790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.